Relationship between monocyte/lymphocyte ratio and non-culprit plaque vulnerability in patients with acute coronary

Ting-Yu Zhang1, Qi Zhao1, Ze-Sen Liu2

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University.

Medicine
|October 8, 2020
PubMed

Insights

The monocyte/lymphocyte ratio (MLR) is linked to vulnerable coronary plaques in acute coronary syndrome patients. Higher MLR indicates increased plaque vulnerability, suggesting its potential as a non-invasive biomarker.

Area of Science:

  • Cardiology
  • Immunology
  • Medical Imaging

Background:

  • Monocyte/lymphocyte ratio (MLR) is implicated in coronary artery disease (CAD) development.
  • Limited research exists on the association between MLR and coronary plaque vulnerability.
  • Acute coronary syndrome (ACS) necessitates understanding plaque instability for risk stratification.

Purpose of the Study:

  • To investigate the relationship between MLR and non-culprit plaque vulnerability in ACS patients.
  • To assess plaque morphology and vulnerability features using optical coherence tomography (OCT).
  • To determine if MLR can predict vulnerable plaque characteristics like thin-cap fibro-atheroma (TCFA).

Main Methods:

  • Retrospective analysis of 72 ACS patients undergoing coronary angiography and OCT.
  • Assessment of plaque vulnerability and morphology via OCT imaging.
  • Statistical analysis including correlation, logistic regression, and diagnostic performance evaluation of MLR.

Main Results:

  • Higher MLR group showed more vulnerable plaques: thinner fibrous caps, larger lipid cores, and longer lipid plaque lengths.
  • Significant negative correlation between MLR and fibrous cap thickness (R=-0.225, P=.005).
  • Increased prevalence of TCFA (P=.014) and plaque rupture (P=.017) in high MLR group; MLR independently predicted TCFA (OR=3.316, P=.005).

Conclusions:

  • Circulating MLR is a potential non-invasive biomarker for identifying vulnerable coronary plaques in ACS patients.
  • Elevated MLR is associated with specific vulnerable plaque features and independently predicts TCFA.
  • MLR may serve as a valuable indicator of inflammation-related plaque vulnerability.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
118
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
244
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
253
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
291
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
238
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
451